KK
AGIO icon

KLP Kapitalforvaltning’s Agios Pharmaceuticals AGIO Stock Holding History

KLP Kapitalforvaltning’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$438K Hold
11,800
– – ﹤0.01% 1560
2026
Q1 		$399K Hold
11,800
– – ﹤0.01% 1527
2025
Q4 		$321K Hold
11,800
– – ﹤0.01% 1633
2025
Q3 		$474K Hold
11,800
– – ﹤0.01% 1424
2025
Q2 		$392K Buy
11,800
+1,800
+18% +$54.6K ﹤0.01% 1473
2025
Q1 		$293K Hold
10,000
– – ﹤0.01% 1571
2024
Q4 		$329K Buy
+10,000
New +$470K ﹤0.01% 1598

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

KLP Kapitalforvaltning's AGIO Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Agios Pharmaceuticals (AGIO) position steady in Q2 2026 at 11,800 shares worth $438K. The position accounts for ﹤0.01% of the portfolio, ranked #1560.

KLP Kapitalforvaltning first reported a position in AGIO in Q4 2024 and has held it in 7 quarters since. The position peaked at $474K in Q3 2025. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • KLP Kapitalforvaltning held 11,800 shares of Agios Pharmaceuticals worth $438K as of Q2 2026.
  • KLP Kapitalforvaltning left its Agios Pharmaceuticals share count unchanged in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1560 holding.
  • KLP Kapitalforvaltning first reported a position in Agios Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Agios Pharmaceuticals position peaked at $474K in Q3 2025.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.